Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2021 10:00 ET | Source: Ellume Health

Ellume Establishes Flagship U.S. Manufacturing Facility in Maryland

Ellume establishes state-of-the-art diagnostic manufacturing facility in Frederick, Maryland, which is on track to begin limited operation in second half 2021;The facility was funded by a $231.8...
March 10, 2021 02:30 ET | Source: Ellume Health; Cambridge Consultants

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021 (GLOBE...
February 01, 2021 14:17 ET | Source: Ellume Health

Ellume Announces $231.8 Million Agreement with the U.S. Government to Scale Up Production of COVID-19 Home Tests

The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S....
December 15, 2020 11:29 ET | Source: Ellume Health

FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals The test demonstrated 96% accuracy in a multi-site US...
December 09, 2020 09:00 ET | Source: Ellume Health

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home testClinical study demonstrated overall sensitivity of 95% and specificity of...
October 06, 2020 15:30 ET | Source: Ellume Health

Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics

VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Ellume, the company reimagining digital diagnostics, today announced a $30 million Phase 2 award from the U.S. National Institutes of Health...